Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5589 USD | -2.72% | +11.76% | +6.99% |
May. 10 | Earnings Flash (KPRX) KIORA PHARMACEUTICALS Posts Q1 Revenue $16M | MT |
Mar. 25 | Kiora Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | 16.75M | Sales 2025 * | 2M | Capitalization | 14.67M |
---|---|---|---|---|---|
Net income 2024 * | 4M | Net income 2025 * | -13M | EV / Sales 2024 * | 0.88 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 7.34 x |
P/E ratio 2024 * |
4.47
x | P/E ratio 2025 * |
-2.02
x | Employees | 12 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.14% |
1 day | -2.72% | ||
1 week | +11.76% | ||
Current month | +11.20% | ||
1 month | +13.99% | ||
3 months | -6.18% | ||
6 months | -0.20% | ||
Current year | +6.99% |
Managers | Title | Age | Since |
---|---|---|---|
Brian Strem
CEO | Chief Executive Officer | 44 | 21-07-25 |
Melissa Tosca
DFI | Director of Finance/CFO | 44 | 22-09-12 |
Stefan Sperl
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Praveen Tyle
CHM | Chairman | 64 | 08-05-31 |
Carmine Stengone
BRD | Director/Board Member | 48 | 23-07-31 |
Aron Shapiro
BRD | Director/Board Member | 46 | 21-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-21 | 0.5589 | -2.72% | 243,471 |
24-05-20 | 0.5745 | +0.79% | 211,310 |
24-05-17 | 0.57 | -1.98% | 152,650 |
24-05-16 | 0.5815 | +12.91% | 459,690 |
24-05-15 | 0.515 | +2.98% | 47,072 |
Delayed Quote Nasdaq, May 21, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.99% | 15.08M | |
+8.63% | 115B | |
+13.17% | 107B | |
-12.76% | 22.31B | |
-3.99% | 21.6B | |
-7.19% | 18.23B | |
-39.93% | 17.62B | |
+6.67% | 14.26B | |
+33.90% | 12.37B | |
-28.60% | 8.28B |
- Stock Market
- Equities
- KPRX Stock